Szexuálisan terjedo koinfekciók. HIV koinfekciók

Orvosi Hetilap

Volumn 156, Issue 1, 2015, Pages 4-9

  Marschalkó, Márta ^a   Pónyai, Katinka ^a   Kárpáti, Sarolta ^a  

^a NONE   (Hungary)

Author keywords

chlamydia; coinfections; gonorrhoea; hepatitis B; hepatitis C; HIV; STD; STI; syphilis

Indexed keywords

CYTOKINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE TRANSMISSION; EPITHELIUM; GONORRHEA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION PREVENTION; INFECTION RISK; MIXED INFECTION; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT RISK; POPULATION; PROGNOSIS; RISK ASSESSMENT; SCREENING TEST; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED COINFECTION; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TISSUE INJURY; COMPLICATION; HEALTH; HIV INFECTIONS; IMMUNOLOGY; RISK FACTOR; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ANTI-HIV AGENTS; CHLAMYDIA INFECTIONS; COINFECTION; GLOBAL HEALTH; GONORRHEA; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; RISK FACTORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; TREATMENT OUTCOME;

EID: 84920018851     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2015.30076     Document Type: Article

References (50)

1. Fleming, D. T., Wasserheit, J. N: From epidemiological synergy to public health policy and practice. The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect., 1999, 75(1), 3-17.
2. Cohen, M. S.: Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet, 1998, 351(Suppl. 3), 5-7.
3. Rogers, A. S., Lindsey, J. C., Futterman, D. C., et al.: Serologic examination of hepatitis B infection and immunization in HIVpositive youth and associated risks. The Pediatric AIDS Clinical Trials Group Protocol 220 Team. AIDS Patient Care STDs, 2000, 14(12), 651-657.
4. Kiire, C. F.: The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut, 1996, 38(Suppl. 2), S5-S12.
5. Hoffmann, C. J., Charalambous, S., Martin, D. J., et al.: Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin. Infect. Dis., 2008, 47(11), 1479-1485.
6. Matthews, P., Geretti, A. M., Goulder, P. J., et al.: Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. J. Clin. Virol., 2014, 61(1), 20-33.
7. Burnett, R. J., François, G., Kew, M. C., et al.: Hepatitis B virus and human immunodefi ciency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int., 2005, 25(2), 201-213.
8. Hoffmann, C. J., Dayal, D., Cheyip, M., et al.: Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South-Africa. Int. J. STD AIDS, 2012, 23(10), e10-e13.
9. Bodsworth, N. J., Cooper, D. A., Donovan, B.: The infl uence of human immunodefi ciency virus type I infection on the development of the hepatitis B virus carrier state. J. Infect. Dis., 1991, 163(5), 1138-1140.
10. Ioannou, G. N., Bryson, C. L., Weiss, N. S., et al.: The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodefi ciency virus infection. Hepatology, 2013, 57(1), 249-257.
11. Nikolopoulos, G. K., Paraskevis, D., Hatzitheodorou, E., et al.: Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin. Infect. Dis., 2009, 48(12), 1763-1771.
12. Wandeler, G., Gsponer, T., Bihl, F., et al.: Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J. Infect. Dis., 2013, 208(9), 1454-1458.
13. Stabinski, L., Reynolds, S. J., Ocama, P., et al.: High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir. Ther., 2011, 16(3), 405-411.
14. Dervisevic, S., Pillay, D.: Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection. J. HIV Ther., 2003, 8(4), 89-95.
15. Petty, L. A., Steinbeck, J. L., Pursell, K., et al.: Human immunodefi ciency virus and coinfection with hepatitis B and C. Infect. Dis. Clin. North Am., 2014, 28(3), 477-499.
16. Di Bisceglie, A. M., Maskew, M., Schulze, D., et al.: HIV-HVB coinfection among South African patient receiving antiretroviral therapy. Antivir. Ther., 2010, 15(3 Pt B), 499-503.
17. Soriano, V., Puoti, M., Peters, M., et al.: Care of HIV patients with chronic hepatitis B: updated recommendations from the HIVHepatitis B Virus International Panel. AIDS, 2008, 22(12), 1399-1410.
18. Rockstroh, J. K., Bhagani, S., Benhamou, Y., et al.: European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med., 2008, 9(2), 82-88.
19. Antonucci, G., Mazzotta, F., Angeletti, C., et al.: Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy. BMC Res. Notes, 2013, 6, 153.
20. Brook, G., Main, J., Nelson, M., et al.: British HIV association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus. HIV Med., 2010, 11(1), 1-30.
21. Moss, W. J., Clements, C. J., Halsey, N. A.: Immunization of children at risk of infection with human immunodefi ciency virus. Bull. World Health Organ., 2003, 81(1), 61-70.
22. Whitaker, J. A., Rouphael, N. G., Edupuganti, S., et al.: Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect. Dis., 2012, 12(12), 966-976.
23. Sulkowski, M. S., Thomas, D. L.: Hepatitis C in the HIV-infected person. Ann. Intern. Med., 2003, 138(3), 197-207.
24. Thomas, D. L., Astemborski, J., Rai, M. R., et al.: The natural history of hepatitis C virus infection: host, viral and environmental factors. JAMA, 2000, 284(4), 450-456.
25. Ragni, M. V., Belle, S. H.: Impact of human immunodefi ciency virus infection on progression of end-stage liver disease in individual with haemophilia and hepatitis C virus infection. J. Infect. Dis., 2001, 183(7), 1112-1115.
26. Clausen, L. N., Lundbo, L. F., Benfield, T.: Hepatitis C virus infection in the human immunodefi ciency virus infected patient. World J. Gastroenterol., 2014, 20(34), 12132-12143.
27. Shah, N., Pierce, T., Kowdley, K. V.: Review of direct-acting antiviral agents for the treatment of chronic hepatitis C. Expert Opin. Investig. Drugs, 2013, 22(9), 1107-1121.
28. Spaulding, A. B., Lifson, A. R., Iverson, E. R., et al., Infectious Disease Clinical Research Program HIV Working Group: Gonorrhoea or chlamydia in a U.S. military HIV-positive cohort. Sex. Transm. Infect., 2012, 88(4), 266-271.
29. Page, K. R., Moore, R. D., Wilgus, B., et al.: Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodefi-ciency virus-infected women. Sex. Trans. Dis., 2008, 35(10), 859-861.
30. Cohen, M. S., Hoffman, I. F., Royce, R. A., et al.: Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet, 1997, 349(9069), 1868-1873.
31. Mitchell, C., Hitti, J., Paul, K., et al.: Cervicovaginal shedding of HIV type 1 is related to genital tract infl ammation independent of changes in vaginal microbiota. AIDS Res. Hum. Retroviruses, 2011, 27(1), 35-39.
32. Bebell, L. M., Passmore, J. A., Williamson, C., et al.: Relationship between levels of infl ammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. J. Infect. Dis., 2008, 198(5), 710-714.
33. Körber, A., Dissemond, J., Lehnen, M., et al.: Syphilis bei HIVkoinfektion. J. Dtsch. Dermatol. Ges., 2004, 2(10), 833-840.
34. Weintrob, A. C., Crum-Cianflone, N., Michael, N. L.: Syphilis and human immunodefi ciency virus coinfection: more than the sum of its parts. Infect. Dis. Clin. Practice, 2006, 14(4), 197-203.
35. Kofoed, K., Gerstoft, J., Mathiesen, L., et al.: Syphilis and human immundefi ciency virus HIV-1 coinfection: infl uence on CD4 Tcell count, HIV-1 viral load, and treatment response. Sex. Transm. Dis., 2006, 33(3), 143-148.
36. Buchacz, K., Patel, P., Taylor, M., et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS, 2004, 18(15), 2075-2079.
37. Sadiq, S. T., McSorley, J., Copas, A. J., et al.: The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex. Transm. Infect., 2005, 81(15), 380-385.
38. Sammet, S. C., Niedermeier, A., Bogner, J., et al.: Unusual faces of syphilis. Hautarzt, 2012, 63(5), 415-422.
39. Tyler, K. L., Sandberg, E., Baum, K. F.: Medical medullary syndrome and meningovascular syphilis: a case report in an HIVinfected man and a review of the literature. Neurology, 1994, 44(12), 2231-2235.
40. Pónyai, K., Ostorházi, E., Mihalik, N., et al.: Syphilis and HIV coinfection-Hungarian Sexually Transmitted Infection Centre experience between 2005 and 2013. Acta Microbiol. Immunol. Hung., 2013, 60(3), 247-259.
41. Tóth, V., Hornyák, Cs., Kovács, T., et al.: Meningovascular neurosyphilis as the cause of ischemic cerebrovascular disease in a young man. [Meningovascularis neurosyphilis miattifiatalkori ischaemiás cerebrovascularis betegség.]. Orv. Hetil. 2011, 152 (19), 763-767. [Hungarian].
42. Mayer, K. H.: Sexually transmitted diseases in men who have sex with men. Clin. Infect. Dis., 2011, 53(Suppl.), S79-S83.
43. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm. Rep., 2008, 57(RR-9), 1-83.
44. Professional Body of Dermatology and Venereal Diseases: Methodological guideline for the diagnosis and treatment of sexually transmitted infections-2002. [Br-és Nemibetegségek Szakmai Kollégiuma: Módszertani ajánlás a szexuális úton terjed infekciók kivizsgálására és kezelésére-2002.] Egészségügyi Közlöny, 2002, 52 (11), 1509-1518. [Hungarian]
45. Fenton, K., Breban, R., Vardavas, R., et al.: Infectious syphilis in high income settings in the 21st century. Lancet Infect. Dis., 2008, 8(4), 244-253.
46. Jinno, S., Ankern B., Kaur, P., et al.: Predictors of serological failure after treatment in HIV-infected patients with early syphilis in the emerging era of universal antiretroviral therapy use. BMC Infect. Dis., 2013, 13, 605.
47. Muldoon, E. G., Mooka, B., Reidy, D., et al.: Long-term neurological follow-up of HIV-positive patients diagnosed with syphilis. Int. J. STD AIDS, 2012, 23(9), 676-678.
48. Luger, A. F., Schmidt, B. L., Kaulich, M.: Signifi cance of laboratory fi ndings for the diagnosis of neurosyphilis. Int. J. STD AIDS, 2000, 11(4), 224-234.
49. Fleming, D. T., Wasserheit, J. N.: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect., 1999, 75(1), 3-17.
50. Paavonen, J.: Immunopathogenesis of pelvic infl ammatory disease and infertility-what do we know, what shall we do J. Br. Fert. Soc., 1996, 1(1), 42-45.